Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cancer

Author： Davide Radice   Alberto Redaelli  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.1, 2005-01, pp. : 69-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Q-TWiST favours epirubicin-containing regimen in breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Bilateral Sensorineural Hearing Loss after Adjuvant Treatment with Cyclophosphamide, Methotrexate, Fluorouracil and Alternative Oral Medications in a Male with Breast Cancer

By Marioni Gino  

Clinical Drug Investigation, Vol. 25, Iss. 4, 2005-01 ,pp. : 277-280

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/epirubicin/fluorouracil: Myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/epirubicin/fluorouracil: Erythrodysaesthesia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II – III invasive breast cancer: the OOTR-N001 study

By Chow Louis WC   Tung Stewart Y   Ng Ting-Ying   Im Seock-Ah   Lee Min-Hyuk   Yip Adrian YS   Toi Masakazu   Glück Stefan  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 299-307

Informa Healthcare

Access to resources Recommend Favorite